Abstract
Hemophilia B is an X-linked recessive bleeding disorder caused by abnormalities of the coagulation factor IX gene (F9). Insertion mutations in F9 ranging from a few to more than 100 base pairs account for only a few percent of all hemophilia B cases. We investigated F9 to elucidate genetic abnormalities causing severe hemophilia B in a Japanese subject. We performed PCR-mediated analysis of F9 and identified a large insertion in exon 6. Next, we carried out direct sequencing of a PCR clone of the whole insert using nested deletion by exonuclease III and S1 nuclease. We identified an approximately 2.5-kb SINE-VNTR-Alu (SVA)-F element flanked by 15-bp duplications in the antisense orientation in exon 6. Additionally, we carried out exontrap analysis to assess the effect of this retrotransposition on mRNA splicing. We observed that regular splicing at exons 5 and 6 of F9 was disturbed by the SVA retrotransposition, suggesting that abnormal FIX mRNA may be reduced by nonsense-mediated mRNA decay. In conclusion, this is the first report of SVA retrotransposition causing severe hemophilia B; only five cases of LINE-1 or Alu retrotranspositions in F9 have been reported previously.
Similar content being viewed by others
References
Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry. 1985;24:3736–50.
Bolton-Maggs PHB, Pasi KJ. Haemophilias A and B. Lancet. 2003;361:1801–9.
Li T, Miller CH, Payne AB, Craig Hooper W. The CDC hemophilia B mutation project mutation list: a new online resource. Mol Genet Genomic Med. 2013;1:238–45.
Kojima T, Tanimoto M, Kamiya T, Obata Y, Takahashi T, Ohno R, et al. Possible absence of common polymorphisms in coagulation factor IX gene in Japanese subjects. Blood. 1987;69:349–52.
Okumura K, Fujimori Y, Takagi A, Murate T, Ozeki M, Yamamoto K, et al. Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia B. Haemophilia. 2008;14:1088–93.
Kato I, Takagi Y, Ando Y, Nakamura Y, Murata M, Takagi A, et al. A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms. Int J Hematol. 2014;100:200–5.
Takagi A, Kojima T, Tsuzuki S, Katsumi A, Yamazaki T, Sugiura I, et al. Structural organization and promoter activity of the human ryudocan gene. J Biochem. 1996;119:979–84.
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921.
Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, et al. LINE-1 retrotransposition activity in human genomes. Cell. 2010;141:1159–70.
Raiz J, Damert A, Chira S, Held U, Klawitter S, Hamdorf M, et al. The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res. 2012;40:1666–83.
Hancks DC, Kazazian HH. Active human retrotransposons: variation and disease. Curr Opin Genet Dev. 2012;22:191–203.
Callinan PA, Batzer MA. Retrotransposable elements and human disease. Genome Dyn. 2006;1:104–15.
Kaer K, Speek M. Retroelements in human disease. Gene. 2013;518:231–41.
Taniguchi-Ikeda M, Kobayashi K, Kanagawa M, Yu CC, Mori K, Oda T, et al. Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature. 2011;478:127–31.
Conley ME, Partain JD, Norland SM, Shurtleff SA, Kazazian HH. Two independent retrotransposon insertions at the same site within the coding region of BTK. Hum Mutat. 2005;25:324–5.
Wilund KR, Yi M, Campagna F, Arca M, Zuliani G, Fellin R, et al. Molecular mechanisms of autosomal recessive hypercholesterolemia. Hum Mol Genet. 2002;11:3019–30.
Makino S, Kaji R, Ando S, Tomizawa M, Yasuno K, Goto S, et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet. 2007;80:393–406.
Hancks DC, Ewing AD, Chen JE, Tokunaga K, Kazazian HH. Exon-trapping mediated by the human retrotransposon SVA. Genome Res. 2009;19:1983–91.
Acknowledgments
The authors thank Ms. C. Wakamatsu for her expert technical assistance and Ms. M. Goto for data collection. This study was financially supported in part by the Japanese Ministry of Education, Culture, Sports, Science, and Technology Subsidy Program (25293129: T. Kojima) and the Japanese Ministry of Health, Labour and Welfare Research Subsidy Program (T. Kojima and M. S.). The authors would like to thank Enago (www.enago.jp) for the English language review.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Nakamura, Y., Murata, M., Takagi, Y. et al. SVA retrotransposition in exon 6 of the coagulation factor IX gene causing severe hemophilia B. Int J Hematol 102, 134–139 (2015). https://doi.org/10.1007/s12185-015-1765-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-015-1765-5